Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies With Targeted ATG Dosing Pilot Study, IDE 13641

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05794880
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:51.999961+00:00
Published At
2025-04-29T00:00:00+00:00
Record Updated At
2025-04-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Leukemia", "Acute Myeloid Leukemia in Remission", "Myelodysplasia", "Acute Lymphoblastic Leukemia in Remission", "Chronic Myelogenous Leukemia - Chronic Phase", "Chronic Myelogenous Leukemia, Accelerated Phase", "Chronic Myelogenous Leukemia With Crisis of Blast Cells", "Biphenotypic Acute Leukemia", "Lymphoblastic Lymphoma", "Burkitt Lymphoma", "Burkitt Leukemia", "Lymphoma After Relapse", "Other Malignant Hematologic Diseases in Remission"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-29"
protocolSection.identificationModule.nctId
"NCT05794880"
protocolSection.identificationModule.officialTitle
"Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies With Targeted ATG Dosing Pilot Study, IDE 13641"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Myelodysplasia (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia - Chronic Phase (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia, Accelerated Phase (protocolSection.conditionsModule.conditions)
  • Chronic Myelogenous Leukemia With Crisis of Blast Cells (protocolSection.conditionsModule.conditions)
  • Biphenotypic Acute Leukemia (protocolSection.conditionsModule.conditions)
  • Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
  • Burkitt Leukemia (protocolSection.conditionsModule.conditions)
  • Lymphoma After Relapse (protocolSection.conditionsModule.conditions)
  • Other Malignant Hematologic Diseases in Remission (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.